A Case of Main Pulmonary Artery Aneurysm Associated with Patent Ductus Arteriosus

1989 ◽  
Vol 19 (2) ◽  
pp. 343
Author(s):  
Hong Lyeol Lee ◽  
Myong Ki Hong ◽  
Kyung Kwon Paik ◽  
Seung Jae Tahk ◽  
Woong Ku Lee ◽  
...  
Keyword(s):  
Pulmonary Artery ◽  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
Main Pulmonary Artery ◽  
Artery Aneurysm ◽  
Pulmonary Artery Aneurysm ◽  
Patent Ductus

scholarly journals Pulmonary Artery Aneurysm Mimicking a Patent Ductus Arteriosus

2020 ◽  
Vol 2 (4) ◽  
pp. 670-671
Author(s):  
Bram Ruijsink ◽  
Phuoc Duong ◽  
Isra Valverde ◽  
Alessandra Frigiola
Keyword(s):  
Pulmonary Artery ◽  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
Artery Aneurysm ◽  
Pulmonary Artery Aneurysm ◽  
Patent Ductus

scholarly journals N-Butyl cyanoacrylate embolization of a peripheral pulmonary artery aneurysm in a patient with patent ductus arteriosus

2019 ◽  
Vol 15 ◽  
Author(s):  
Mahmoud Goudarzi
Keyword(s):  
Pulmonary Artery ◽  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
Artery Aneurysm ◽  
Massive Hemoptysis ◽  
Pulmonary Artery Aneurysm ◽  
Embolization Treatment ◽  
Clinical Background ◽  
History Of ◽  
Patent Ductus

: N-Butyl cyanoacrylate embolization of peripheral pulmonary artery aneurysms has rarely been performed. This report presents a young woman with history of patent ductus arteriosus and massive hemoptysis secondary to pulmonary artery aneurysm, successfully managed by embolotherapy using N-Butyl cyanoacrylate. This is the first report of n-Butyl cyanoacrylate embolization treatment of a bleeding pulmonary artery aneurysm in the setting of patent ductus arteriosus. The pertinent literature has been reviewed and the clinical background as well as the procedure have been explained.

scholarly journals Giant Pulmonary Artery Aneurysm in a 40-Year-Old Woman after Patent Ductus Arteriosus Ligation at 2 Years of Age

2016 ◽  
Vol 43 (3) ◽  
pp. 274-276 ◽  
Author(s):  
Arun Kannan ◽  
Scott Lick ◽  
Michael F. Teodori ◽  
Eric Brody ◽  
Rajesh Janardhanan
Keyword(s):  
Pulmonary Artery ◽  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
Artery Aneurysm ◽  
Pulmonary Artery Aneurysm ◽  
Patent Ductus

Echocardiographic diagnosis of a mycotic aneurysm of the main pulmonary artery and patent ductus arteriosus

1992 ◽  
Vol 123 (6) ◽  
pp. 1707-1709 ◽  
Author(s):  
Jesus Vargas-Barron ◽  
Lucrecia Avila-Rosales ◽  
Angel Romero-Cardenas ◽  
Maria Rijlaarsdam ◽  
Candace Keirns ◽  
...  
Keyword(s):  
Pulmonary Artery ◽  
Patent Ductus Arteriosus ◽  
Mycotic Aneurysm ◽  
Ductus Arteriosus ◽  
Main Pulmonary Artery ◽  
Patent Ductus

scholarly journals Hospital Outcomes of Surgical Closure of Patent Ductus Arteriosus: 19 Years Experience at Shahid Gangalal National Heart Center

2020 ◽  
Vol 18 (2) ◽  
pp. 30-35
Author(s):  
R. Koirala ◽  
N. Panthee ◽  
S. Pradhan ◽  
N. Rajbhandari ◽  
D.K. Shrestha ◽  
...  
Keyword(s):  
Pulmonary Artery ◽  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
Main Pulmonary Artery ◽  
Pulmonary Artery Hypertension ◽  
Hospital Outcomes ◽  
Descending Aorta ◽  
Surgical Closure ◽  
First Case ◽  
Patent Ductus

Background Ductus arteriosus is a vascular structure which connects the roof of main pulmonary artery near the origin of the left branch pulmonary artery to the proximal descending aorta. Patent ductus arteriosus (PDA) closure is indicated for any patient who is symptomatic from left to right shunting. Objective To investigate the hospital outcomes of surgical closure of patent ductus arteriosus over last 19 years starting from the very first case of our center. Method This is a retrospective analysis of all patent ductus arteriosus treated surgically from August 2001 to July 2019. Patients who underwent isolated surgical closure of patent ductus arteriosus were included. Data have been presented in three different eras (Era 1: 2001-2007, Era 2: 2008-2013, and Era 3: 2014-2019) to see the trend of evolution of this surgery. Result A total of 901 patients aged 8.67±8.76 years under went patent ductus arteriosus surgical closure over last 19 years. Patients in the initial era 2001-2007 were significantly older compared with other 2 eras (p=0.000). Males accounted for 35.5% of all cases. Twenty percent had severe pulmonary artery hypertension. Duration of mechanical ventilation was 3.57±9.64 hours with ICU stay of 1.55±1.53 days, and hospital stay of 3.9±2.3 days. Overall in hospital mortality was 0.8%; for isolated patent ductus arteriosus diagnosis, mortality was 0.2%. Chylothorax was noted in 0.4%. Conclusion This is the first report to analyze surgical outcomes of patent ductus arteriosus ligation in our center. We have discussed the evolution of patent ductus arteriosus surgery in our center, and have shown favorable outcomes in terms of morbidity and mortality.

Abstract 10972: Transthoracic Echocardiography-guided Percutaneous Patent Ductus Arteriosus Occlusion: A New Strategy For Interventional Treatment

Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Xiang-Bin Pan ◽  
Wen-Bin Ouyang ◽  
Shou-Zheng Wang ◽  
Yao Liu ◽  
Da-Wei Zhang ◽  
...  
Keyword(s):  
Pulmonary Artery ◽  
Patent Ductus Arteriosus ◽  
Transthoracic Echocardiography ◽  
Guide Wire ◽  
Ductus Arteriosus ◽  
Main Pulmonary Artery ◽  
Interventional Treatment ◽  
Residual Shunt ◽  
Patent Ductus

Objectives: This prospective single center study investigated the safety and efficacy of percutaneous patent ductus arteriosus (PDA) occlusion using the Amplatzer Duct Occluder II (ADO II) under only guidance of transthoracic echocardiography, which avoids the radiation and contrast agents of traditional PDA occlusion. Methods: From June 2013 to February 2015, 54 consecutive PDA patients (age, 4.6 ± 2.9 years; weight, 18.5 ± 7.5 kg; PDA narrowest diameter, 3.3 ± 1.1 mm) underwent transthoracic echocardiography guided PDA occlusion through the femoral artery. Outpatient follow-up was conducted at 1, 3, and 6 months, and yearly. Results: Echocardiography-guided percutaneous PDA occlusion was successfully performed in 53 patients. The procedure was converted to minimally invasive transthoracic occlusion in one patient due to failure of delivery catheter passage through tortuous PDA. Mean procedure duration was 25.5 ± 7.4 minutes; ADO II diameter averaged 4.7 ± 0.9 mm; 8 cases showed traces of residual shunt immediately after operation; and mean hospital stay was 3.4 ± 0.7 days. There was no occluder migration, hemolysis or pericardial effusion at mean 10.2±4.9 months follow-up. Conclusions: Percutaneous PDA occlusion under only guidance of transthoracic echocardiography appears safe and effective while avoiding radiation and contrast agent use. Legends: A) A suprasternal view showed the tip of pigtail catheter (arrow) faced the aortic end of the PDA. B) The left parasternal long axis view of the pulmonary artery showed that the guide wire (arrow) was located within the main pulmonary artery. C) The release of the occluder at the pulmonary side (arrow). D) The occluder was completely released (arrows point to each side of the occluder). PDA, patent ductus arteriosus; DAO, descending aorta; PA, pulmonary artery; AO, ascending aorta.

Sign in / Sign up

Export Citation Format

Share Document